Thrombotargets Europe, S.L.
Ignasi Miquel
Address: TTE-BARCELONA: Parc Mediterrani de la Tecnologia, Av Canal olímpic s/n, Edif B6, 2ªPlanta
City: 08860-Castelldefels
Province: Barcelona
Phone: 34 93 664 20 40
Fax: 34 93 635 07 12
Mission and Objectives
Thrombotargets Europe is a clinical stage Biotech company focused on the development of new therapeutic treatments in the field of haemostasis. To achieve this goal Thrombotargets has developed proprietary High Throughput Screening Technologies that allow the speed-up of the Drug Discovery process for the identification of innovative drugs that may improve the quality of life of the human being.
Products/Services, Areas of interest for future collaborations/Alliances
1) TT-173 (Topical Hemostat for treatment of surgical bleeding, Phase II)
2)Several programs focused on haemostasis and coagulation (anticoagulants, antifibrinolytics).
3) Technological Platforms: BIOPLATFORMSCREEN (High Throughput Screening in haemostasis for the detection of anticoagulants, procoagulants, fibrinolytics, antifibrinolytics…)
1) Collaborations in HTS projects; identification and development of new drugs in haemostasis
2)Development of tt-173 containing sealants/patche.
3) Biomarkers to be integrated in biosensor-based diagnosis platform (POC in Alzheimer)

Thrombotargets Europe, S.L.
Developed by Web4Bio